BOB CAT: a large-scale review and Delphi consensus for management of Barrett's esophagus with no dysplasia, indefinite for, or low-grade dysplasia

C Bennett, P Moayyedi, DA Corley… - Official journal of the …, 2015 - journals.lww.com
OBJECTIVES: Barrett's esophagus (BE) is a common premalignant lesion for which
surveillance is recommended. This strategy is limited by considerable variations in clinical …

Endoscopic screening for Barrett's esophagus and esophageal adenocarcinoma: rationale, candidates, and challenges

AK Kamboj, DA Katzka, PG Iyer - Gastrointestinal Endoscopy …, 2021 - giendo.theclinics.com
There are approximately 18,440 new cases of esophageal cancer and 16,170 deaths from
esophageal cancer annually. 1 Esophageal cancer has 2 histologic subtypes …

Barrett's oesophagus and bariatric/metabolic surgery—IFSO 2020 position statement

OM Fisher, DL Chan, ML Talbot, A Ramos, A Bashir… - Obesity Surgery, 2021 - Springer
Abstract The International Federation for the Surgery of Obesity and Metabolic Disorders
(IFSO) has been playing an integral role in educating both the metabolic surgical and the …

Quality indicators for the management of Barrett's esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the …

P Sharma, DA Katzka, N Gupta, J Ajani, N Buttar… - Gastroenterology, 2015 - Elsevier
The development of and adherence to quality indicators in gastroenterology, as in all of
medicine, is increasing in importance to ensure that patients receive consistent high-quality …

Incidence of esophageal adenocarcinoma and causes of mortality after radiofrequency ablation of Barrett's esophagus

WA Wolf, S Pasricha, C Cotton, N Li, G Triadafilopoulos… - Gastroenterology, 2015 - Elsevier
Background & Aims Radiofrequency ablation (RFA) is commonly used to treat Barrett's
esophagus (BE). We assessed the incidence of esophageal adenocarcinoma (EAC) after …

[HTML][HTML] S3-Leitlinie Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus (Langversion 1.0–September 2015, AWMF …

R Porschen, A Buck, W Fischbach… - Zeitschrift für …, 2015 - thieme-connect.com
Die Medizin unterliegt einem fortwährenden Entwicklungsprozess, sodass alle Angaben,
insbesondere zu diagnostischen und therapeutischen Verfahren, immer nur dem …

[HTML][HTML] S3-Leitlinie–Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des ösophagus

R Porschen, W Fischbach, I Gockel… - Zeitschrift für …, 2019 - thieme-connect.com
Thieme E-Journals - Zeitschrift für Gastroenterologie / Full Text DE EN Home Products Journals
Books Book Series Service Library Service Help Contact Portal Zeitschrift für Gastroenterologie …

Cancer incidence and mortality risks in a large US Barrett's oesophagus cohort

MB Cook, SB Coburn, JR Lam, PR Taylor… - Gut, 2018 - gut.bmj.com
Objective Barrett's oesophagus (BE) increases the risk of oesophageal adenocarcinoma by
10–55 times that of the general population, but no community-based cancer-specific …

[HTML][HTML] Lifetime risk of esophageal adenocarcinoma in patients with Barrett's esophagus

P Gatenby, C Caygill, C Wall… - World journal of …, 2014 - ncbi.nlm.nih.gov
AIM: To investigate the lifetime risk of development of esophageal adenocarcinoma and/or
high-grade dysplasia in patients diagnosed with Barrett's esophagus. METHODS: Data were …

Barrett's esophagus and esophageal adenocarcinoma biomarkers

WM Grady, M Yu, SD Markowitz, A Chak - Cancer Epidemiology, Biomarkers …, 2020 - AACR
Esophageal adenocarcinoma is a major cause of cancer-related morbidity and mortality in
Western countries. The incidences of esophageal adenocarcinoma and its precursor …